Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on April 12, 2007

Under the agreement, Roche will acquire an exclusive license for TG 4001 and further vaccine candidates resulting from the collaboration in HPV-mediated diseases, and will have exclusive worldwide commercialization rights.Transgene will receive 13 million Euros as an upfront payment and 10 million Euros as a near-term regulatory milestone payment related to planning the Phase III studies. Further details on the terms of agreement from the Roche's and Transgene's (pdf file) press releases.
Permalink: Roche Licences Transgene's HPV Vaccines
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/63063
Mr Wong
Vote for Roche Licences Transgene's HPV Vaccines:
|
Rating: 8.75 out of 4 vote(s) cast.
|
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |







